Key facts
- StrongRoom AI’s last known valuation is $70.0M (Mar 2025).
- It has raised $31.1M; the latest was Merger/Acquisition in Jun 2025.
- Status: Acquired/Merged.
- ·Watchlist + deal alerts for StrongRoom AI
- ·The full record, as it builds
Funding rounds
No funding rounds for StrongRoom AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About StrongRoom AI
Developer of an AI-driven controlled drugs management platform designed to reduce adverse drug events within the pharmacy. The company's platform helps in the medication management of patients, medical supply inventory control, and drug registry management, enabling clients to eliminate errors, improve accuracy, and automate compliance.
- Sector
- Healthcare
- HQ
- Melbourne, Australia
- Founded
- 2017
- Employees
- 39
- Website
- strongroom.ai/
- Ownership
- Acquired/Merged
StrongRoom AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in StrongRoom AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on StrongRoom AI in its N-PORT filings yet. We sweep new filings monthly.